Cargando…

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy?

Detalles Bibliográficos
Autores principales:	Kim, Hyun Kuk, Tantry, Udaya S., Gurbel, Paul A., Jeong, Young-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440994/ https://www.ncbi.nlm.nih.gov/pubmed/32812410 http://dx.doi.org/10.4070/kcj.2020.0287

Ejemplares similares

Temporal Variability of Platelet Reactivity Phenotype: Another Barrier to Personalized Antiplatelet Strategy Guided by Platelet Function Testing
por: Jeong, Young-Hoon, et al.
Publicado: (2019)

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences
por: Kim, Hyun Kuk, et al.
Publicado: (2021)

Personalized antiplatelet therapy: state of the art
por: Gurbel, Paul A, et al.
Publicado: (2012)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

In Vitro Evidence for the Role of Cytokine Storm in the Generation of Stent Thrombosis in COVID-19 Patients
por: Gurbel, Paul A., et al.
Publicado: (2022)

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015)

Further evidence for the use of aspirin in COVID-19
por: Tantry, Udaya S., et al.
Publicado: (2022)

International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
por: Gurbel, Paul A., et al.
Publicado: (2021)

State of the art: Oral antiplatelet therapy
por: Gurbel, Paul A, et al.
Publicado: (2016)

Rigorous and consistent evaluation of diagnostic tests in children: another unmet need
por: Caldwell, Christine S., et al.
Publicado: (2020)

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO Trial
por: Park, Hyun-Woong, et al.
Publicado: (2021)

Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent
por: Tantry, Udaya S, et al.
Publicado: (2021)

Unmet Needs for Cardiovascular Care in Indonesia
por: Maharani, Asri, et al.
Publicado: (2014)

Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations
por: Chaudhary, Rahul, et al.
Publicado: (2020)

Influence of Race and Sex on Thrombogenicity in a Large Cohort of Coronary Artery Disease Patients
por: Lev, Eli I., et al.
Publicado: (2014)

Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention
por: Ahn, Jong-Hwa, et al.
Publicado: (2022)

Intersection of class, caste, gender and unmet healthcare needs in India: Implications for health policy
por: Mahapatro, Sandhya R., et al.
Publicado: (2021)

Cardiovascular Research in Friedreich Ataxia: Unmet Needs and Opportunities
por: Payne, R. Mark
Publicado: (2022)

High-Dose, but Not Low-Dose, Aspirin Impairs Anticontractile Effect of Ticagrelor following ADP Stimulation in Rat Tail Artery Smooth Muscle Cells
por: Grześk, Grzegorz, et al.
Publicado: (2013)

Correlated Motions and Residual Frustration in Thrombin
por: Fuglestad, Brian, et al.
Publicado: (2013)

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2021)

IS LOW DOSE ASPIRIN EFFECTIVE IN REDUCING IN-HOSPITAL CLINICAL OUTCOMES IN PATIENTS WITH COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

Unmet needs in asthma
por: Gruffydd-Jones, Kevin
Publicado: (2019)

High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need
por: Cimmino, Giovanni, et al.
Publicado: (2014)

Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease
por: Kosmas, Constantine E, et al.
Publicado: (2019)

Application of Cancer Genomics to Solve Unmet Clinical Needs
por: Lee, Se-Hoon, et al.
Publicado: (2013)

Unmet needs in rheumatoid arthritis
por: Moreland, Larry
Publicado: (2005)

Unmet needs in the management of schizophrenia
por: Torres-González, Francisco, et al.
Publicado: (2014)

Unmet psychosocial needs in CAPS
por: Erbis, G, et al.
Publicado: (2015)

Editorial: Unmet Needs in Dystonia
por: Albanese, Alberto
Publicado: (2017)

Radiologic Gastrostomy: An Unmet Need!
por: Kumar, Mukesh, et al.
Publicado: (2021)

Epidemiology and Unmet Needs in Hypertension
por: Flack, John M.
Publicado: (2007)

The Unmet Need for Artificial Saliva
por: Katsnelson, Alla
Publicado: (2023)

Unmet Needs in Geriatric Oncology
por: Pathi, Nikhil, et al.
Publicado: (2023)

Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
por: Tuttolomondo, Antonino, et al.
Publicado: (2023)

Unmet Needs for Care and Medications, Cost as a Reason for Unmet Needs, and Unmet Needs as a Big Problem, due to Health-Care Provider (Dis)Continuity
por: Stransky, Michelle L
Publicado: (2018)

Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7pmjj99jn377bouplvmp89rk89